Eugen Musch, Tamim Lutfi, Petra von Stein, Arezou Zargari, Charlotte Admyre, Mouhamad Malek, Robert Löfberg and Oliver D. von Stein Topical treatment with the toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity Inflammatory Bowel Diseases
Article first published online: 17 MAY 2012 | DOI: 10.1002/ibd.23019
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.